JPM has a key level of support at $105 (green). The stock looks like it may be making its way back down to that level again, and traders should be able to expect some sort of a bounce from there, if it does. JPMorgan Chase & Co. operates as...
Read More
Today saw stocks open deep in the red, only to bounce back and close with back with just minor losses. “Buy the dip” still seems to be the mantra, and still seems to be working. But for how much longer? Today we look at a troubling recession...
Read More
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. Take a look at the 1-year chart of Hologic...
Read More
Aimmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes product candidates for the treatment of peanut and other food allergies. Take a look at the 1-year chart of Aimmune (NASDAQ: AIMT) with the...
Read More
Agnico Eagle Mines Limited engages in the exploration, development, and production of mineral properties in Canada, Mexico, and Finland. The company operates through Northern Business and Southern Business segments. Take a look at the 1-year...
Read More
Apple Inc. designs, manufactures, and markets mobile communication and media devices, and personal computers to consumers, and small and mid-sized businesses; and education, enterprise, and government customers worldwide. The company also sells...
Read More
Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It operates in two segments, Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). Take a look at the 1-year chart of Pfizer (NYSE: PFE) below with...
Read More